Gum Grafting Market

The Global Gum Grafting Market is estimated to be valued at USD 479.5 Mn in 2025 and is expected to reach USD 832.4 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.2% from 2025 to 2032. The global gum grafting market represents a specialized segment within the broader periodontal therapy landscape, addressing critical oral health challenges related to gum recession and tissue loss. Gum grafting, also known as gingival grafting, is a surgical procedure designed to restore receded gum tissue by transplanting healthy tissue from other areas of the patient's mouth or utilizing donor materials.

This therapeutic intervention has gained significant traction as awareness about periodontal health's impact on overall systemic health continues to expand. The market encompasses various grafting techniques including connective tissue grafts, free gingival grafts, and pedicle grafts, each tailored to specific clinical scenarios and patient needs. Rising prevalence of periodontal diseases, increasing geriatric population susceptible to gum recession, and growing emphasis on aesthetic dentistry are driving market expansion. Advanced biomaterials, minimally invasive surgical techniques, and improved patient outcomes have further enhanced the adoption of gum grafting procedures.

Market Dynamics

The global gum grafting market is propelled by several compelling drivers that underscore its robust growth trajectory, while simultaneously facing certain restraints and presenting lucrative opportunities for industry participants. Primary market drivers include the escalating prevalence of periodontal diseases worldwide, with studies indicating that severe periodontitis affects approximately 10-15% of the global adult population, creating substantial demand for therapeutic interventions like gum grafting.

The aging demographic represents another significant driver, as elderly individuals are more susceptible to gum recession due to natural aging processes, medication side effects, and accumulated oral health challenges over time. Growing awareness of the connection between oral health and systemic conditions such as cardiovascular disease, diabetes, and respiratory infections has heightened patient motivation to seek periodontal treatments.

Technological advancements in grafting materials, including development of synthetic and xenograft alternatives that reduce donor site morbidity, have expanded treatment accessibility and improved patient acceptance. However, the market faces notable restraints including high treatment costs that may limit accessibility for certain patient populations, particularly in developing regions where healthcare spending remains constrained.

Limited insurance coverage for periodontal procedures in many jurisdictions creates financial barriers for patients. Additionally, the specialized nature of gum grafting procedures requires experienced practitioners, and the shortage of trained periodontists in certain geographic areas may restrict market growth.

Key Features of the Study

• This report provides in-depth analysis of the global gum grafting market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global gum grafting market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Geistlich Pharma AG, Dentsply Sirona, Straumann Group, botiss biomaterials GmbH, BioHorizons, CAMLOG Biotechnologies GmbH, ZimVie, Collagen Matrix Inc., Osteogenics Biomedical Inc., Datum Dental Ltd., Sunstar GUIDOR, Integra LifeSciences, Bioteck S.p.A., Purgo Biologics, and Nobel Biocare
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global gum grafting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gum grafting market

Market Segmentation

• Procedure Type Insights (Revenue, USD Mn, 2020 - 2032)
• Connective Tissue Graft (CTG)
• Free Gingival Graft (FGG)
• Pedicle Graft (Lateral Pedicle)
• Acellular Dermal Matrix (ADM) Allograft
• Tissue-Engineered Grafts
• Material Type Insights (Revenue, USD Mn, 2020 - 2032)
• Autografts (Patient's Own Tissue)
• Allografts (Human Donor Tissue)
• Xenografts (Animal-Derived Tissue, e.g., Bovine/Porcine)
• Alloplasts (Synthetic Materials)
• Product Type Insights (Revenue, USD Mn, 2020 - 2032)
• Biological Membranes
• Collagen Matrices
• Tissue Scaffolds
• Bone Graft Substitutes
• Regenerative Biomaterials
• Indication Insights (Revenue, USD Mn, 2020 - 2032)
• Gingival Recession Coverage (Teeth)
• Peri-implant Soft-Tissue Augmentation
• Keratinized Tissue Width Increase
• Ridge/Soft-Tissue Thickening Pre-Prosthetics
• Mucogingival Defects post-Orthodontics/Trauma
• Age Group Insights (Revenue, USD Mn, 2020 - 2032)
• Pediatric/Adolescent
• Adult
• Geriatric
• End User Insights (Revenue, USD Mn, 2020 - 2032)
• Hospitals
• Dental Clinics
• Academic and Research Institutes
• Ambulatory Surgical Centers
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Geistlich Pharma AG
• Dentsply Sirona
• Straumann Group
• botiss biomaterials GmbH
• BioHorizons
• CAMLOG Biotechnologies GmbH
• ZimVie
• Collagen Matrix Inc.
• Osteogenics Biomedical Inc.
• Datum Dental Ltd.
• Sunstar GUIDOR
• Integra LifeSciences
• Bioteck S.p.A.
• Purgo Biologics
• Nobel Biocare

Show more